Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations
Cynthia E. Ortiz, Haley Maria Dourron, Noah W Sweat, Albert Garcia‐romeu, Sarah Maccarthy, B. Anderson, Peter S. Hendricks
Neuropharmacology May 13, 2022 DOI: 10.1016/j.neuropharm.2022.109127 via OpenAlex
Summary
AI-generated from the abstractPsilocybin-facilitated psychotherapy may be effective across many mental health conditions, but vulnerable populations, who carry a disproportionate mental health burden, have been largely excluded from clinical research. This report highlights the need to include these groups in studies, considering their problematic historical context and differential experiences with psychedelics. It offers actionable recommendations for future research, such as improved recruitment strategies, careful communication of subjective effects, building therapeutic alliance, multicultural competence, and flexible study designs. The authors call for expanded and improved research in this rapidly advancing field.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Mental health Context archaeology Alliance Psychotherapist |
| Citations | 26 |
| Key finding | Vulnerable populations have been neglected in psilocybin-facilitated psychotherapy research, and future studies must prioritize their inclusion through culturally competent and flexible approaches. |
Abstract
Psilocybin-facilitated psychotherapy shows potential transdiagnostic efficacy for a range of mental health conditions. Though vulnerable populations bear disproportionate mental health burden, they have been largely neglected in the clinical psilocybin literature. However, if the field is to best respond to the diverse needs of individuals from vulnerable populations, care must be taken to ensure these individuals are represented in the empirical research. This report calls attention to this concern by detailing the challenges and opportunities associated with evaluating psilocybin-facilitated psychotherapy in vulnerable populations. First, we show how working with vulnerable populations must be considered in the context of an often-problematic past and differential exposure to and experience with classic psychedelics. We then provide actionable recommendations for future research testing psilocybin-facilitated psychotherapy in vulnerable populations, including an emphasis on recruitment strategies, the appropriate communication and assessment of subjective effects, building therapeutic alliance, multicultural competence, and flexible study designs. On these premises we call for future work in this area, underscoring that there is vast room for improvement and expansion in this rapidly advancing field of study.